Normal
9th - 10th March 2023

MarketsandMarkets Precision Medicine Conference

London, UK

Harnessing the potential of Precision Medicine From Bench To Bedside

The healthcare sector is accelerating on a trajectory from ubiquitous treatment to truly personalized treatment. The advent of precision medicine has paved ways for customization and preventive health strategy development by utilizing the genetic information of the individual along with ethnicity, environment exposures, medical history and more. Surging trends in tailoring care have been a driving force for extensive research in this field from data research to target drug discovery.

MarketsandMarkets is delighted to announce its Precision Medicine Conference scheduled to be held on 9th-10th March 2023 in London, UK. The conference is intended to have interactive sessions on precision medicine, application of pharmacogenomics, complex diseases prediction and treatment, technological advancements in diagnosis of diseases, artificial intelligence and bigdata, challenges and ethical considerations in precision medicine.

The event encompasses networking sessions, panel discussions, solutions, and services catering to precision medicine. The conference will bring the full spectrum of experts, leaders, and stakeholders to share a board prospective on opportunities and overcoming the challenges faced during implementation of precision medicine in clinical practice.

WHAT TO EXPECT

Key Highlights

  1. Overview of Precision Medicine and Genomic Science
  2. Precision Medicine in complex disease prediction and treatment – Chronic diseases, CAR T- cell immunotherapy in solid tumors
  3. Comprehensive Genomic profiling - Single cell sequencing using Liquid biopsy, Genetic screening by nextgeneration sequencing and whole genome sequencing
  4. Use of digital biomarkers for drug development, Multi-Omics prospects (Epigenomics, Proteomics, Transcriptomics, Pharmaco genomics)
  5. Inception of technologies for Precision Medicine – Impact of big data, Artificial intelligence, and Machine Learning, Insilico trials for Precision medicine
  6. Cost benefit issues, Regulatory, Ethical and Social challenges in Precision Medicine
  7. Future purview of Precision Medicine, New beginning – Digital health

Why Attend ?

  • Witness live action how precision medicine is revolutionizing the future of healthcare
  • Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing precision medicine
  • Discover the different avenues in patient centric care
  • Comprehend the current and future regulatory prospects for approval of diagnostic tests
  • Discuss the emerging technologies and opportunities with cutting edge strategies
  • Opportunity for one-on-one networking with the delegates and extend professional competency
  • Panel discussion with great lineup of experts

Who should attend?

  • Industry: Pharma/Therapeutic Companies/Start Up’s
  • CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Immunologists, Geneticists, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
  • Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology
  • Academics: Universities, Research Institutes, Hospitals
  • Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
  • Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology

CONFERENCE AGENDA
END OF DAY 1 followed by Drinks, Reception and Networking
Precision Medicine in Disease Prediction & Treatment
Precision Medicine and Pharmacogenomics
Future Purview of Precision Medicine
END OF DAY 2
CONFERENCE SPEAKERS
Advisors
Alex F Frangi
Alex F Frangi
Diamond Jubilee Chair in Computational Medicine & RAEng Chair in Emerging Technologies, University of Leeds & KU Leuven - Turing Fellow
Manuel Corpas
Manuel Corpas
Scientific Director, Cambridge Precision Medicine
Arunima Ghosh
Arunima Ghosh
Managing director Indivumed Inc VP, Clinical network, USA, Indivumed
Lahiri Kanth Nanduri
Lahiri Kanth Nanduri
Lead Scientific Officer, FlowCell
Speakers
John Maher
John Maher
Scientific Founder and Chief Scientific Officer, Leucid Bio
Dr Steve Gardner
Dr Steve Gardner
CEO and Co-founder, PrecisionLife, UK
Jennifer Barnett
Jennifer Barnett
CEO, Monument Therapeutics
Christoph A. Merten
Christoph A. Merten
, École Polytechnique Fédérale de Lausanne (EPFL)
Andrew Pierce
Andrew Pierce
Vice President, Translational Biology, Crescendo Biologics
Arijit  Mukhopadhyay
Arijit Mukhopadhyay
Reader in Human Genetics, University of Salford
Hemant  Dhamne
Hemant Dhamne
Head Gene and Cell Therapy, Kings College London
Sabina Patel
Sabina Patel
Director, Diagnostic Expert, AstraZeneca
LOCATION
London, UK
About the Hotel

PAST EVENT GALLERY